Facts & figures

Indicators: Community

XLS

Spending on community involvement (€ million)

 

 

 

 

 

 

 

 

 

 

 

2012

 

2013

 

2014

 

20151

1

The figure does not include data from Sigma-Aldrich since the integration process is still underway.

Total spending

 

11.8

 

46.2

 

50.8

 

100.0

We calculate the value of pharmaceutical product donations according to the WHO Guidelines for Medicine Donations; for other product donations, we apply their fair value.

The increase in our community involvement spending is attributable to the expansion of our Praziquantel Donation Program as well as the expansion of the Erbitux® China Patient Assistance Program. In the Praziquantel Donation Program, we are partnering with the World Health Organization to combat the worm disease schistosomiasis in African school children. Through the Erbitux® China Patient Assistance Program, roughly 90% of the costs for Erbitux® treatment can be covered for colorectal cancer patients with a good prognosis.

XLS

Spending on community involvement, by region (%)1

 

 

 

 

 

 

 

 

 

 

 

2012

 

2013

 

2014

 

20152

1

Excluding spending for the Global Pharma Health Fund, the Praziquantel Donation Program and the Deutsche Philharmonie Merck sponsored by Merck KGaA, Darmstadt, Germany. As regards segment reporting by country and region, the composition of regions was adjusted and the corresponding comparative year-earlier figures are presented. The regional reporting structure now comprises five regions: Europe, North America, Asia-Pacific, Latin America as well as Middle East and Africa.

2

The figures exclude Sigma-Aldrich since the integration process is still underway.

Europe

 

20

 

36

 

37

 

8

North America

 

13

 

1

 

< 2

 

1

Asia-Pacific (APAC)

 

59

 

61

 

60

 

91

Latin America

 

8

 

< 1

 

< 2

 

< 1

Middle East and Africa (MEA)

 

< 1

 

< 1

 

< 1

 

< 1

In 2015, the significant increase in spending on the Erbitux® China Patient Assistance Program led to a relative decrease in spending in other regions.

XLS

Focus of local community involvement (%)1

 

 

 

 

 

 

 

 

 

 

 

2012

 

2013

 

2014

 

20152

1

Based on number of projects, excluding the Global Pharma Health Fund, the Praziquantel Donation Program and Deutsche Philharmonie Merck sponsored by Merck KGaA, Darmstadt, Germany.

2

The figures exclude data from Sigma-Aldrich since the integration process is still underway.

Disaster relief

 

3

 

6

 

4

 

6

Education

 

16

 

23

 

23

 

25

Environment

 

9

 

10

 

10

 

7

Health

 

30

 

23

 

33

 

33

Support for culture and sports activities near our sites

 

28

 

19

 

15

 

8

Other

 

14

 

19

 

15

 

21

XLS

Motivations for our community involvement (%)1

 

 

 

 

 

 

 

 

 

 

 

2012

 

2013

 

2014

 

20152

1

Based on total spending, excluding spending for the Global Pharma Health Fund, the Praziquantel Donation Program and the Deutsche Philharmonie Merck sponsored by Merck KGaA, Darmstadt, Germany.

2

The figures exclude Sigma-Aldrich since the integration process is still underway.

Charitable activities

 

32

 

20

 

9

 

3

Community investment

 

52

 

59

 

59

 

92

Commercial initiatives in the community

 

16

 

21

 

32

 

5

In 2015, the significant increase in spending on the Erbitux® China Patient Assistance Program, which falls under "Community investment", led to a relative decrease in spending in other areas.

We assign the motivations for our engagement to categories based on the model of the London Benchmarking Group as well as the guidelines of the Bertelsmann Foundation for corporate social engagement. Projects that primarily aim to make improvements within the community are classified as "community investment".

Projects that are predominantly aimed at company-relevant factors such as image or personnel recruitment are classified as "commercial initiatives in the community". "Charitable activities” comprehends any other projects that benefit a charitable organization, but cannot be assigned to either of the other two motivation categories due to missing data or their narrow scope.